GlassScriptPhysician profile
Erin E Mcmurray
NPI 1073770772
$3,406.37
in general payments reported to CMS, 2019-2025
20 companies · $602 in 2025
The $602 reported for 2025 was more than what 77% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $567 · 2022: $633 · 2023: $627 · 2024: $977 · 2025: $602.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,206.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $743.81 | 2021-2025 | Azstarys |
| Tris Pharma INC | $705.69 | 2021-2025 | Dyanavel Xr |
| Supernus Pharmaceuticals, INC. | $451.43 | 2021-2025 | Qelbree |
| Ironshore Pharmaceuticals INC. | $289.50 | 2022-2024 | Jornay Pm |
| Pfizer INC. | $210.79 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $188.84 | 2021-2025 | Gardasil 9, Vaxneuvance, M-M-R II |
| Sanofi Pasteur INC. | $159.40 | 2021-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $131.51 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $96.94 | 2025 | Jornay Pm |
| Adlon Therapeutics L.P. | $82.24 | 2021 | |
| Cranial Technologies, INC | $78.80 | 2023-2025 | Doc Band |
| Ultragenyx Pharmaceutical INC. | $58.40 | 2021-2025 | Dojolvi, Crysvita |
| Seqirus USA INC | $51.46 | 2022-2025 | Flucelvax |
| Teva Pharmaceuticals USA, INC. | $47.33 | 2021 | |
| Sobi, INC | $27.01 | 2021-2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $20.19 | 2025 | |
| Neurelis, INC. | $19.37 | 2024 | Valtoco |
| Exeltis, USA INC. | $15.98 | 2024 | Slynd |
| Lnhc, INC | $13.91 | 2025 | Zelsuvmi |
| Ironwood Pharmaceuticals, INC | $13.77 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Mcmurray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.